19
Jun
2024

Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.

Exhibitor at CPHI & PMEC China 2024 stand E3B18, Finished Dosage
About Us

Shijiazhung Lonzeal Pharmaceuticals is one of the largest pharmaceutical manufacturers of anti-HIV drugs in China. Current ARV product line covers Lamivudine, Emtricitabine, Tenofovir and their intermediates. Our API product has been GMP certified by multiple drug authorities including WHO, China CFDA and Brazil ANVISA, also registered in Russia, South Africa and India. We now continuously export to esteemed multi-national pharmaceutical companies. Other APIs produced by Lonzeal are Esomeprazole, Paroxetine and Oxiracetam. We look forward to develop long term cooperation with all customers ...

  • CN
  • 2015
    On CPHI since
Contact info
Event information
CPHI & PMEC China 2024
  • 19 June 2024 - 21 June 2024
  • Shanghai New International Expo Center
  • Visit us at stand E3B18, Finished Dosage

Products Featured at CPHI & PMEC China 2024

  • Baloxavir Marboxil

    Product Baloxavir Marboxil

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Baloxavir Marboxil. Product not provided to where patent is still valid
  • Pregabalin

    Product Pregabalin

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Pregabalin.
  • Emtricitabine

    Product Emtricitabine

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Emtricitabine.
  • Lamivudine

    Product Lamivudine

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes lamivudine. It belongs to antiviral drugs APIi category. APIplication: anti-viral drug substance. Contact us for more information.
  • Tenofovir Alafenamide Fumarate(TAF)

    Product Tenofovir Alafenamide Fumarate(TAF)

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes TAF.  Product not provided to where patent is still valid